Aleš Janda

2.4k total citations
44 papers, 661 citations indexed

About

Aleš Janda is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Aleš Janda has authored 44 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Infectious Diseases. Recurrent topics in Aleš Janda's work include Immunodeficiency and Autoimmune Disorders (12 papers), Immune Cell Function and Interaction (7 papers) and COVID-19 Clinical Research Studies (6 papers). Aleš Janda is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (12 papers), Immune Cell Function and Interaction (7 papers) and COVID-19 Clinical Research Studies (6 papers). Aleš Janda collaborates with scholars based in Germany, Czechia and United States. Aleš Janda's co-authors include Anna Šedivá, Marta Rizzi, Philipp Henneke, Stephan Ehl, Hubert Schrezenmeier, P Kasal, Klaus Schwarz, Anne Rensing‐Ehl, Ondřej Hrušák and Tomáš Kalina and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Aleš Janda

42 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aleš Janda Germany 17 303 178 94 92 90 44 661
Yoshiko Hashii Japan 19 227 0.7× 222 1.2× 82 0.9× 72 0.8× 113 1.3× 127 1.1k
Concetta Micalizzi Italy 22 267 0.9× 331 1.9× 152 1.6× 86 0.9× 124 1.4× 81 1.2k
Susanna Fischer Austria 17 518 1.7× 166 0.9× 77 0.8× 65 0.7× 118 1.3× 36 1.2k
Francesca Mazzetta Italy 17 480 1.6× 160 0.9× 94 1.0× 123 1.3× 210 2.3× 21 863
Marco Chiarini Italy 19 502 1.7× 214 1.2× 260 2.8× 88 1.0× 138 1.5× 61 1.0k
Daisuke Tomizawa Japan 21 216 0.7× 391 2.2× 56 0.6× 93 1.0× 103 1.1× 139 1.4k
Jack Bartram United Kingdom 18 94 0.3× 185 1.0× 96 1.0× 71 0.8× 123 1.4× 50 883
M. Garcia-Lloret United States 15 788 2.6× 230 1.3× 89 0.9× 107 1.2× 230 2.6× 25 1.3k
César Núnêz United States 13 324 1.1× 118 0.7× 108 1.1× 50 0.5× 135 1.5× 56 863
Nick Goulden United Kingdom 21 246 0.8× 173 1.0× 70 0.7× 51 0.6× 76 0.8× 33 1.8k

Countries citing papers authored by Aleš Janda

Since Specialization
Citations

This map shows the geographic impact of Aleš Janda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleš Janda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleš Janda more than expected).

Fields of papers citing papers by Aleš Janda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleš Janda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleš Janda. The network helps show where Aleš Janda may publish in the future.

Co-authorship network of co-authors of Aleš Janda

This figure shows the co-authorship network connecting the top 25 collaborators of Aleš Janda. A scholar is included among the top collaborators of Aleš Janda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleš Janda. Aleš Janda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janda, Aleš. (2025). Stellenwert des Vitamin D bei Autoimmunerkrankungen. Arthritis und Rheuma. 45(1). 44–50.
2.
Kuemmerle‐Deschner, Jasmin, Tilmann Kallinich, Jörg Henes, et al.. (2024). Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry. RMD Open. 10(1). e003890–e003890. 9 indexed citations
3.
Goldberg‐Bockhorn, Eva, et al.. (2024). Increase in acute mastoiditis at the end of the COVID-19 pandemic. European Archives of Oto-Rhino-Laryngology. 281(9). 4747–4756. 7 indexed citations
4.
Stich, Maximilian, Louise Benning, Claudius Speer, et al.. (2023). Live‐virus neutralization of the omicron variant in children and adults 14 months after SARS‐CoV‐2 wild‐type infection. Journal of Medical Virology. 95(3). e28582–e28582. 1 indexed citations
5.
Bode, Sebastian, et al.. (2023). Characterization of adolescents with functional respiratory disorders and prior history of SARS-CoV-2. SHILAP Revista de lepidopterología. 10(1). 10–10. 1 indexed citations
6.
Seidel, Alina, Eva‐Maria Jacobsen, Dorit Fabricius, et al.. (2023). Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection. Frontiers in Pediatrics. 11. 1020865–1020865. 2 indexed citations
7.
Bode, Sebastian, Dorit Fabricius, Benjamin Mayer, et al.. (2022). Pulmonary Function and Persistent Clinical Symptoms in Children and Their Parents 12 Months After Mild SARS-CoV-2 Infection. Frontiers in Pediatrics. 10. 894331–894331. 5 indexed citations
8.
Pfeil, Johannes, Ulrich von Both, Aleš Janda, et al.. (2022). Infektiologische Versorgung minderjähriger Flüchtlinge am Beispiel der Ukraine. Monatsschrift Kinderheilkunde. 170(12). 1103–1112. 1 indexed citations
9.
Bemtgen, Xavier, Karin Klingel, Markus Hufnagel, et al.. (2021). Case Report: Lymphohistiocytic Myocarditis With Severe Cardiogenic Shock Requiring Mechanical Cardiocirculatory Support in Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection. Frontiers in Cardiovascular Medicine. 8. 716198–716198. 16 indexed citations
11.
Janda, Aleš, Hubert Fahnenstich, Christoph Müller, et al.. (2021). High diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the diagnosis of adolescent pulmonary tuberculosis. BMC Infectious Diseases. 21(1). 946–946. 7 indexed citations
12.
Janda, Aleš, Maximilian Heeg, Nadine Binder, et al.. (2020). Comprehensive infectious disease screening in a cohort of unaccompanied refugee minors in Germany from 2016 to 2017: A cross-sectional study. PLoS Medicine. 17(3). e1003076–e1003076. 22 indexed citations
13.
Janda, Aleš, et al.. (2020). Patient satisfaction & use of health care: a cross-sectional study of asylum seekers in the Freiburg initial reception centre. BMC Health Services Research. 20(1). 709–709. 5 indexed citations
14.
Janda, Aleš, Klaus Schwarz, Mirjam van der Burg, et al.. (2016). Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome. Blood. 127(18). 2193–2202. 20 indexed citations
15.
Dostálová, Taťjana, et al.. (2010). Evaluation of 5-year Experience with E-learning Techniques at Charles University in Prague. Impact on Quality of Teaching and Students’ Achievements. The New Educational Review. 21(2). 110–120. 3 indexed citations
16.
Janda, Aleš, et al.. (2009). Immunohistochemical Prognostic Markers in Intracranial Ependymomas: Systematic Review and Meta-Analysis. Pathology & Oncology Research. 15(4). 605–614. 12 indexed citations
17.
Šedivá, Anna, Smith Rjh, Anna Asplund, et al.. (2007). Contiguous X-chromosome Deletion Syndrome Encompassing the BTK, TIMM8A, TAF7L, and DRP2 Genes. Journal of Clinical Immunology. 27(6). 640–646. 24 indexed citations
19.
Janda, Aleš, et al.. (2005). Link popularity and other quality criteria used in evaluation of paediatric information resources on the internet. Technology and Health Care. 13(5). 406–407.
20.
Kasal, P, et al.. (2005). Evaluation of health care related web resources based on web citation analysis and other quality criteria. PubMed. 12. 2391–2394. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026